Xospata Gilteritinib — Carefirst Caremark
4 indications indexed for this drug.
- Flt3 Mutation Positive Acute Myeloid Leukemia Aml Without IdView coverage criteria
- Flt3 Mutation Positive Aml As Maintenance Therapy Post AllogView coverage criteria
- Flt3 Mutation Positive Aml Relapsed Or Refractory DiseaseView coverage criteria
- Myeloid Lymphoid Neoplasms With Eosinophilia With Flt3 RearrView coverage criteria